{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T03:09:59Z","timestamp":1768792199791,"version":"3.49.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002674","name":"Russian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.yexcr.2020.111882","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T11:00:05Z","timestamp":1580554805000},"page":"111882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Human artificial chromosomes for pluripotent stem cell-based tissue replacement therapy"],"prefix":"10.1016","volume":"389","author":[{"given":"Sergey A.","family":"Sinenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey V.","family":"Ponomartsev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey N.","family":"Tomilin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2020.111882_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2020.111882_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrg1829","article-title":"Genetic medicines: treatment strategies for hereditary disorders","volume":"7","author":"O'Connor","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0079-6603(08)60169-5","article-title":"Insertional mutations in transgenic mice","volume":"36","author":"Costantini","year":"1989","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1101\/gad.1.4.366","article-title":"Retroviruses and insertional mutagenesis in mice: proviral integration at the Mov 34 locus leads to early embryonic death","volume":"1","author":"Soriano","year":"1987","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2020.111882_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-genet-112414-054926","article-title":"From genomics to gene therapy: induced pluripotent stem cells meet genome editing","volume":"49","author":"Hotta","year":"2015","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/513287a","article-title":"Japan stem-cell trial stirs envy","volume":"513","author":"Reardon","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2020.111882_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-61779-370-7_8","article-title":"Adeno-associated virus mediated gene therapy for retinal degenerative diseases","volume":"807","author":"Stieger","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.gene.2013.03.092","article-title":"Gene therapy of primary T cell immunodeficiencies","volume":"525","author":"Fischer","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2020.111882_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.coi.2012.08.008","article-title":"Gene therapy for primary immunodeficiencies: Part 1","volume":"24","author":"Cavazzana-Calvo","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.yexcr.2020.111882_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11684-011-0159-1","article-title":"Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity","volume":"5","author":"Wu","year":"2011","journal-title":"Front. Med."},{"key":"10.1016\/j.yexcr.2020.111882_bib11","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddr142","article-title":"Gene therapy for leukodystrophies","volume":"20","author":"Biffi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1472-6483(10)60557-3","article-title":"Transfer of human artificial chromosome vectors into stem cells","volume":"16","author":"Oshimura","year":"2008","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.yexcr.2020.111882_bib13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.gt.3302483","article-title":"Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts","volume":"12","author":"Kakeda","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1073\/pnas.96.2.592","article-title":"Human artificial chromosomes generated by modification of a yeast artificial chromosome containing both human alpha satellite and single-copy DNA sequences","volume":"96","author":"Henning","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.111882_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/mt.2013.155","article-title":"Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I\/IIa clinical study","volume":"22","author":"Perie","year":"2014","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/d41586-018-05278-8","article-title":"Reprogrammed' stem cells approved to mend human hearts for the first time","volume":"557","author":"Cyranoski","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2020.111882_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050403","article-title":"Current challenges of iPSC-based disease modeling and therapeutic implications","volume":"8","author":"Doss","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2020.111882_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1517\/17425247.2014.882314","article-title":"Human artificial chromosome-based gene delivery vectors for biomedicine and biotechnology","volume":"11","author":"Kouprina","year":"2014","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.yexcr.2020.111882_bib19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00018-012-1113-3","article-title":"A new generation of human artificial chromosomes for functional genomics and gene therapy","volume":"70","author":"Kouprina","year":"2013","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"key":"10.1016\/j.yexcr.2020.111882_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10577-014-9460-6","article-title":"Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes","volume":"23","author":"Tedesco","year":"2015","journal-title":"Chromosome Res. : Int. J. Mol.Supramol. Evol. Aspects Chromosome Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jgm.236","article-title":"Strategies for engineering human chromosomes with therapeutic potential","volume":"4","author":"Saffery","year":"2002","journal-title":"J. Gene Med."},{"key":"10.1016\/j.yexcr.2020.111882_bib22","first-page":"843","article-title":"Human artificial chromosomes: potential applications and clinical considerations","volume":"53","author":"Basu","year":"2006","journal-title":"Pediatr. Clin."},{"key":"10.1016\/j.yexcr.2020.111882_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1042\/BST0340324","article-title":"Progress in artificial chromosome technology","volume":"34","author":"Monaco","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.yexcr.2020.111882_bib24","first-page":"43","article-title":"Human artificial chromosome vectors meet stem cells: new prospects for gene delivery","volume":"2","author":"Ren","year":"2006","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.yexcr.2020.111882_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-61779-099-7_7","article-title":"Construction and use of a bottom-up HAC vector for transgene expression","volume":"738","author":"Ikeno","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib26","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/mt.2011.136","article-title":"Human artificial chromosomes for gene delivery and the development of animal models","volume":"19","author":"Kazuki","year":"2011","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0497-345","article-title":"Formation of de novo centromeres and construction of first-generation human artificial microchromosomes","volume":"15","author":"Harrington","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1083\/jcb.200207112","article-title":"CENP-B box is required for de novo centromere chromatin assembly on human alphoid DNA","volume":"159","author":"Ohzeki","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt0598-431","article-title":"Construction of YAC-based mammalian artificial chromosomes","volume":"16","author":"Ikeno","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2020.111882_bib30","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/nar\/gkg182","article-title":"Cloning of human centromeres by transformation-associated recombination in yeast and generation of functional human artificial chromosomes","volume":"31","author":"Kouprina","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib31","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1093\/nar\/gni129","article-title":"Rapid generation of long synthetic tandem repeats and its application for analysis in human artificial chromosome formation","volume":"33","author":"Ebersole","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib32","doi-asserted-by":"crossref","first-page":"20048","DOI":"10.1073\/pnas.1114483108","article-title":"Human artificial chromosome (HAC) vector with a conditional centromere for correction of genetic deficiencies in human cells","volume":"108","author":"Kim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.111882_bib33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/sb3000436","article-title":"Organization of synthetic alphoid DNA array in human artificial chromosome (HAC) with a conditional centromere","volume":"1","author":"Kouprina","year":"2012","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib34","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.1093\/nar\/gku835","article-title":"Replication of alpha-satellite DNA arrays in endogenous human centromeric regions and in human artificial chromosome","volume":"42","author":"Erliandri","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10577-015-9469-5","article-title":"Recent advances in chromosome engineering","volume":"23","author":"Kouprina","year":"2015","journal-title":"Chromosome Res. : Int. J. Mol.Supramol. Evol. Aspects Chromosome Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib36","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/nar\/gkv124","article-title":"Generation of a conditionally self-eliminating HAC gene delivery vector through incorporation of a tTAVP64 expression cassette","volume":"43","author":"Kononenko","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00412-016-0588-3","article-title":"Transformation-associated recombination (TAR) cloning for genomics studies and synthetic biology","volume":"125","author":"Kouprina","year":"2016","journal-title":"Chromosoma"},{"key":"10.1016\/j.yexcr.2020.111882_bib38","doi-asserted-by":"crossref","first-page":"15275","DOI":"10.18632\/oncotarget.24567","article-title":"Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient","volume":"9","author":"Kouprina","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2020.111882_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-1652-8_1","article-title":"From selective full-length genes isolation by TAR cloning in yeast to their expression from HAC vectors in human cells","volume":"1227","author":"Kouprina","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.devcel.2008.02.001","article-title":"Inactivation of a human kinetochore by specific targeting of chromatin modifiers","volume":"14","author":"Nakano","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.yexcr.2020.111882_bib41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/dnares\/dsq020","article-title":"Human artificial chromosome with a conditional centromere for gene delivery and gene expression","volume":"17","author":"Iida","year":"2010","journal-title":"DNA Res. : Int J. Rapid Publ. Rep. Genes Genomes"},{"key":"10.1016\/j.yexcr.2020.111882_bib42","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1093\/nar\/gkt205","article-title":"Re-engineering an alphoid(tetO)-HAC-based vector to enable high-throughput analyses of gene function","volume":"41","author":"Kononenko","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib43","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1007\/s00018-013-1362-9","article-title":"Protecting a transgene expression from the HAC-based vector by different chromatin insulators, Cellular and molecular life sciences","volume":"70","author":"Lee","year":"2013","journal-title":"CMLS"},{"key":"10.1016\/j.yexcr.2020.111882_bib44","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1080\/15384101.2015.1014151","article-title":"Stable maintenance of de novo assembled human artificial chromosomes in embryonic stem cells and their differentiated progeny in mice","volume":"14","author":"Liskovykh","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yexcr.2020.111882_bib45","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1038\/emboj.2012.82","article-title":"Breaking the HAC Barrier: histone H3K9 acetyl\/methyl balance regulates CENP-A assembly","volume":"31","author":"Ohzeki","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2020.111882_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells7120261","article-title":"Transfer of synthetic human chromosome into human induced pluripotent stem cells for biomedical applications","volume":"7","author":"Sinenko","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2020.111882_bib47","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/acssynbio.8b00018","article-title":"Generation of a synthetic human chromosome with two centromeric domains for advanced epigenetic engineering studies","volume":"7","author":"Pesenti","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2019.06.006","article-title":"Human artificial chromosomes that bypass centromeric DNA","volume":"178","author":"Logsdon","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2020.111882_bib49","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41592-019-0600-y","article-title":"HACs with non-repetitive centromeres","volume":"16","author":"Rusk","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.yexcr.2020.111882_bib50","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/nar\/gkp058","article-title":"Manipulating transgenes using a chromosome vector","volume":"37","author":"Ikeno","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomethods\/bpy013","article-title":"Improving the efficiency of gene insertion in a human artificial chromosome vector and its transfer in human-induced pluripotent stem cells","volume":"3","author":"Hasegawa","year":"2018","journal-title":"Biol. Method Protocols"},{"key":"10.1016\/j.yexcr.2020.111882_bib52","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/hmg\/ddr144","article-title":"Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells","volume":"20","author":"Mandegar","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10577-014-9456-2","article-title":"Developing de novo human artificial chromosomes in embryonic stem cells using HSV-1 amplicon technology","volume":"23","author":"Moralli","year":"2015","journal-title":"Chromosome Res. : Int. J. Mol.Supramol. Evol. Aspects Chromosome Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/mt.2008.253","article-title":"A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene","volume":"17","author":"Hoshiya","year":"2009","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002342","article-title":"Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy","volume":"3","author":"Tedesco","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2020.111882_bib56","doi-asserted-by":"crossref","first-page":"140ra189","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2020.111882_bib57","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/mt.2009.274","article-title":"Complete genetic correction of ips cells from Duchenne muscular dystrophy","volume":"18","author":"Kazuki","year":"2010","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10577-014-9459-z","article-title":"A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges","volume":"23","author":"Oshimura","year":"2015","journal-title":"Chromosome Res. : Int. J. Mol.Supramol. Evol. Aspects Chromosome Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng0697-133","article-title":"Functional expression and germline transmission of a human chromosome fragment in chimaeric mice","volume":"16","author":"Tomizuka","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib60","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/80287","article-title":"Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts","volume":"18","author":"Kuroiwa","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2020.111882_bib61","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2020.111882_bib62","doi-asserted-by":"crossref","first-page":"e17267","DOI":"10.1371\/journal.pone.0017267","article-title":"A method for producing transgenic cells using a multi-integrase system on a human artificial chromosome vector","volume":"6","author":"Yamaguchi","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2020.111882_bib63","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2004.06.145","article-title":"Construction of a novel human artificial chromosome vector for gene delivery","volume":"321","author":"Katoh","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2020.111882_bib64","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1093\/nar\/gni192","article-title":"Iterative in vivo assembly of large and complex transgenes by combining the activities of phiC31 integrase and Cre recombinase","volume":"33","author":"Dafhnis-Calas","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib65","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1634\/stemcells.2005-0021","article-title":"A novel human artificial chromosome vector provides effective cell lineage-specific transgene expression in human mesenchymal stem cells","volume":"23","author":"Ren","year":"2005","journal-title":"Stem Cell."},{"key":"10.1016\/j.yexcr.2020.111882_bib66","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.gt.3303091","article-title":"Correction of a genetic defect in multipotent germline stem cells using a human artificial chromosome","volume":"15","author":"Kazuki","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/gt.2010.147","article-title":"Refined human artificial chromosome vectors for gene therapy and animal transgenesis","volume":"18","author":"Kazuki","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1073\/pnas.74.1.319","article-title":"Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells","volume":"74","author":"Fournier","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.111882_bib69","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00335-003-4002-0","article-title":"Microcell-mediated chromosome transfer (MMCT): small cells with huge potential, Mammalian genome","volume":"14","author":"Doherty","year":"2003","journal-title":"Off. J. Int. Mammalian Genome Soc."},{"key":"10.1016\/j.yexcr.2020.111882_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1247\/csf.14005","article-title":"Recurrent micronucleation through cell cycle progression in the presence of microtubule inhibitors","volume":"40","author":"Nakayama","year":"2015","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.yexcr.2020.111882_bib71","doi-asserted-by":"crossref","first-page":"16043","DOI":"10.1038\/mtm.2016.43","article-title":"Moving toward a higher efficiency of microcell-mediated chromosome transfer, Molecular therapy","volume":"3","author":"Liskovykh","year":"2016","journal-title":"Method Clin. Dev."},{"key":"10.1016\/j.yexcr.2020.111882_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1472-6750-10-37","article-title":"Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer","volume":"10","author":"Katoh","year":"2010","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.yexcr.2020.111882_bib73","doi-asserted-by":"crossref","first-page":"26615","DOI":"10.1074\/jbc.M603053200","article-title":"Human artificial chromosomes constructed using the bottom-up strategy are stably maintained in mitosis and efficiently transmissible to progeny mice","volume":"281","author":"Suzuki","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2020.111882_bib74","first-page":"65","article-title":"A new method of microcell-mediated transfer of human artificial chromosomes using a hemagglutinating virus of Japan envelope","volume":"9","author":"Yamaguchi","year":"2006","journal-title":"Chromosome Sci."},{"key":"10.1016\/j.yexcr.2020.111882_bib75","first-page":"59","article-title":"Measles virus glycoprotein complex assembly, receptor attachment, and cell entry","volume":"329","author":"Navaratnarajah","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.yexcr.2020.111882_bib76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12896-015-0142-z","article-title":"Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome","volume":"15","author":"Hiratsuka","year":"2015","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.yexcr.2020.111882_bib77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.15252\/emmm.201607284","article-title":"Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy","volume":"10","author":"Benedetti","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.yexcr.2020.111882_bib78","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10616-013-9548-4","article-title":"The transfer of human artificial chromosomes via cryopreserved microcells","volume":"65","author":"Uno","year":"2013","journal-title":"Cytotechnology"},{"key":"10.1016\/j.yexcr.2020.111882_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157187","article-title":"Highly efficient transfer of chromosomes to a broad range of target cells using Chinese hamster ovary cells expressing murine leukemia virus-derived envelope proteins","volume":"11","author":"Suzuki","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2020.111882_bib80","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1073\/pnas.77.6.3610","article-title":"Chromosome-mediated gene transfer results in two classes of unstable transformants","volume":"77","author":"Klobutcher","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.111882_bib81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1011680529073","article-title":"Efficient in-vitro transfer of a 60-Mb mammalian artificial chromosome into murine and hamster cells using cationic lipids and dendrimers","volume":"9","author":"de Jong","year":"2001","journal-title":"Chromosome Res. : Int. J. Mol.Supramol. Evol. Aspects Chromosome Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-61779-099-7_4","article-title":"Chromosome transfer via cell fusion","volume":"738","author":"Paulis","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib83","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1634\/stemcells.2007-0052","article-title":"Transfer of a human chromosomal vector from a hamster cell line to a mouse embryonic stem cell line","volume":"25","author":"Paulis","year":"2007","journal-title":"Stem Cell."},{"key":"10.1016\/j.yexcr.2020.111882_bib84","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1093\/nar\/gkp1168","article-title":"Cell to cell transfer of the chromatin-packaged human beta-globin gene cluster","volume":"38","author":"Suzuki","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib85","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/dgd.12419","article-title":"Pluripotency deconstructed","volume":"60","author":"Kinoshita","year":"2018","journal-title":"Dev. Growth Differ."},{"key":"10.1016\/j.yexcr.2020.111882_bib86","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12861-017-0150-4","article-title":"The many faces of Pluripotency: in vitro adaptations of a continuum of in vivo states","volume":"17","author":"Morgani","year":"2017","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib87","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/1566523215666150630121207","article-title":"Pluripotent stem cells for gene therapy of degenerative muscle diseases","volume":"15","author":"Loperfido","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib88","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/mus.23738","article-title":"Gene and cell-mediated therapies for muscular dystrophy","volume":"47","author":"Konieczny","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.yexcr.2020.111882_bib89","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2020.111882_bib90","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.yexcr.2020.111882_bib91","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10286-018-00587-4","article-title":"Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review","volume":"29","author":"Saito-Diaz","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.scr.2017.08.014","article-title":"Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene","volume":"24","author":"Khudiakov","year":"2017","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib93","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.scr.2017.08.015","article-title":"Generation of iPSC line from desmin-related cardiomyopathy patient carrying splice site mutation of DES gene","volume":"24","author":"Khudiakov","year":"2017","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib94","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12015-014-9536-x","article-title":"Ethics of iPSC-based clinical research for age-related macular degeneration: patient-centered risk-benefit analysis","volume":"10","author":"Nakano-Okuno","year":"2014","journal-title":"Stem cell Rev. Rep."},{"key":"10.1016\/j.yexcr.2020.111882_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells5040044","article-title":"Potential of induced pluripotent stem cells (iPSCs) for treating age-related macular degeneration (AMD)","volume":"5","author":"Fields","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2020.111882_bib96","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.scr.2016.04.012","article-title":"Generation of a human iPSC line from a patient with Leigh syndrome caused by a mutation in the MT-ATP6 gene","volume":"16","author":"Galera-Monge","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib97","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.scr.2016.09.031","article-title":"Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance","volume":"17","author":"Varga","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib98","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1242\/dmm.019505","article-title":"Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy","volume":"8","author":"Lin","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.yexcr.2020.111882_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells8010020","article-title":"iPSCs as a platform for disease modeling, drug screening, and personalized therapy in muscular dystrophies","volume":"8","author":"Ortiz-Vitali","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2020.111882_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020169","article-title":"Ex vivo expansion of hematopoietic stem cells for therapeutic purposes: lessons from development and the niche","volume":"8","author":"Tajer","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2020.111882_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060633","article-title":"Pooling of patient-derived mesenchymal stromal cells reduces inter-individual confounder-associated variation without negative impact on cell viability, proliferation and osteogenic differentiation","volume":"8","author":"Widholz","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2020.111882_bib102","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1126\/science.290.5495.1308","article-title":"Genomics and gene therapy. Artificial chromosomes coming to life","volume":"290","author":"Willard","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2020.111882_bib103","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cts.12466","article-title":"Gene therapy 2017: progress and future directions","volume":"10","author":"Keeler","year":"2017","journal-title":"Clin. Trans. Sci."},{"key":"10.1016\/j.yexcr.2020.111882_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: an update","volume":"20","author":"Ginn","year":"2018","journal-title":"J. Gene Med."},{"key":"10.1016\/j.yexcr.2020.111882_bib105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0168-9525(02)02679-3","article-title":"Advances in human artificial chromosome technology","volume":"18","author":"Larin","year":"2002","journal-title":"Trends Genet. : TIG (Trends Genet.)"},{"key":"10.1016\/j.yexcr.2020.111882_bib106","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.21666","article-title":"Ethical and safety issues of stem cell-based therapy","volume":"15","author":"Volarevic","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.yexcr.2020.111882_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8030288","article-title":"iPS-cell technology and the problem of genetic instability-can it ever Be safe for clinical use?","volume":"8","author":"Attwood","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.yexcr.2020.111882_bib108","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.0801677105","article-title":"Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease","volume":"105","author":"Wernig","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.111882_bib109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI40553","article-title":"Progress toward the clinical application of patient-specific pluripotent stem cells","volume":"120","author":"Kiskinis","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2020.111882_bib110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12015-016-9680-6","article-title":"Genomic instability of iPSCs: challenges towards their clinical applications","volume":"13","author":"Yoshihara","year":"2017","journal-title":"Stem cell Rev. Rep."},{"key":"10.1016\/j.yexcr.2020.111882_bib111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","article-title":"Somatic coding mutations in human induced pluripotent stem cells","volume":"471","author":"Gore","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2020.111882_bib112","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/stem.1011","article-title":"Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells","volume":"30","author":"Ji","year":"2012","journal-title":"Stem Cell."},{"key":"10.1016\/j.yexcr.2020.111882_bib113","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2013.07.001","article-title":"Genetic and epigenetic variations in iPSCs: potential causes and implications for application","volume":"13","author":"Liang","year":"2013","journal-title":"Cell stem cell"},{"key":"10.1016\/j.yexcr.2020.111882_bib114","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2009.03.005","article-title":"Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells","volume":"4","author":"Feng","year":"2009","journal-title":"Cell stem cell"},{"key":"10.1016\/j.yexcr.2020.111882_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010108","article-title":"Long-term stability and differentiation potential of cryopreserved cGMP-compliant human induced pluripotent stem cells","volume":"21","author":"Shafa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2020.111882_bib116","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1162494","article-title":"Induced pluripotent stem cells generated without viral integration","volume":"322","author":"Stadtfeld","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2020.111882_bib117","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrg2955","article-title":"Progress in understanding reprogramming to the induced pluripotent state","volume":"12","author":"Plath","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010089","article-title":"End-to-End platform for human pluripotent stem cell manufacturing","volume":"21","author":"Pandey","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2020.111882_bib119","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nbt727","article-title":"Cloned transchromosomic calves producing human immunoglobulin","volume":"20","author":"Kuroiwa","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2020.111882_bib120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nbt.1521","article-title":"Antigen-specific human polyclonal antibodies from hyperimmunized cattle","volume":"27","author":"Kuroiwa","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2020.111882_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130699","article-title":"Species-specific chromosome engineering greatly improves fully human polyclonal antibody production profile in cattle","volume":"10","author":"Matsushita","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2020.111882_bib122","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1023\/A:1026741321193","article-title":"Stability of transferred human chromosome fragments in cultured cells and in mice","volume":"8","author":"Shinohara","year":"2000","journal-title":"Chromosome Res. : Int. J. Mol.Supramol. Evol. Aspects Chromosome Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib123","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1073\/pnas.97.2.722","article-title":"Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies","volume":"97","author":"Tomizuka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.111882_bib124","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbrc.2005.02.079","article-title":"Construction of a novel expression system on a human artificial chromosome","volume":"329","author":"Otsuki","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2020.111882_bib125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nrg1943","article-title":"TAR cloning: insights into gene function, long-range haplotypes and genome structure and evolution","volume":"7","author":"Kouprina","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib126","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1179\/174313209X455718","article-title":"A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells","volume":"32","author":"Kinoshita","year":"2010","journal-title":"Neurol. Res."},{"key":"10.1016\/j.yexcr.2020.111882_bib127","first-page":"318","article-title":"[In vitro derivation and characterization of a colorectal cancer stem cell subpopulation]","volume":"55","author":"Davydov-Sinitsyn","year":"2013","journal-title":"Tsitologiia"},{"key":"10.1016\/j.yexcr.2020.111882_bib128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/acssynbio.7b00209","article-title":"Method to assemble genomic DNA fragments or genes on human artificial chromosome with regulated kinetochore using a multi-integrase system","volume":"7","author":"Lee","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.yexcr.2020.111882_bib129","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/embo-reports\/kvf174","article-title":"Functional human CFTR produced by a stable minichromosome","volume":"3","author":"Auriche","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.yexcr.2020.111882_bib130","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s10038-005-0300-6","article-title":"A novel expression system for genomic DNA loci using a human artificial chromosome vector with transformation-associated recombination cloning","volume":"50","author":"Ayabe","year":"2005","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib131","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bbrc.2008.02.119","article-title":"Telomerase-mediated life-span extension of human primary fibroblasts by human artificial chromosome (HAC) vector","volume":"369","author":"Shitara","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2020.111882_bib132","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10038-005-0334-9","article-title":"Exogenous gene expression and growth regulation of hematopoietic cells via a novel human artificial chromosome","volume":"51","author":"Yamada","year":"2006","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib133","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bbrc.2005.12.106","article-title":"Heat-regulated production and secretion of insulin from a human artificial chromosome vector","volume":"340","author":"Suda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2020.111882_bib134","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/hmg\/dds468","article-title":"Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans","volume":"22","author":"Kazuki","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10038-008-0268-0","article-title":"Introduction of a CD40L genomic fragment via a human artificial chromosome vector permits cell-type-specific gene expression and induces immunoglobulin secretion","volume":"53","author":"Yamada","year":"2008","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025961","article-title":"Integration-free iPS cells engineered using human artificial chromosome vectors","volume":"6","author":"Hiratsuka","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2020.111882_bib137","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1038\/mtna.2015.28","article-title":"Use of a human artificial chromosome for delivering trophic factors in a rodent model of amyotrophic lateral sclerosis","volume":"4","author":"Watanabe","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.yexcr.2020.111882_bib138","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.yexcr.2020.111882_bib139","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/febs.12178","article-title":"Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies","volume":"280","author":"Benedetti","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.yexcr.2020.111882_bib140","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1093\/hmg\/ddv420","article-title":"Progress and prospects of gene therapy clinical trials for the muscular dystrophies","volume":"25","author":"Bengtsson","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib141","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/MOP.0b013e328365ace5","article-title":"Muscular dystrophy: new challenges and review of the current clinical trials","volume":"25","author":"Mercuri","year":"2013","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.yexcr.2020.111882_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mtm.2013.1","article-title":"Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne muscular dystrophy patient-derived cardiomyocytes, Molecular therapy","volume":"1","author":"Zatti","year":"2014","journal-title":"Method Clin. Dev."},{"key":"10.1016\/j.yexcr.2020.111882_bib143","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/jhg.2011.88","article-title":"Integration-free and stable expression of FVIII using a human artificial chromosome","volume":"56","author":"Kurosaki","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib144","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbrc.2012.12.096","article-title":"An induced pluripotent stem cell-mediated and integration-free factor VIII expression system","volume":"431","author":"Yakura","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2020.111882_bib145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/asheducation-2007.1.466","article-title":"Update on progress and hurdles in novel genetic therapies for hemophilia","author":"High","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.yexcr.2020.111882_bib146","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.2011.08925.x","article-title":"Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation","volume":"156","author":"Scott","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexcr.2020.111882_bib147","first-page":"8","article-title":"Toward gene and cell therapies employing human artificial chromosomes in conjunction with stem cells","volume":"3","author":"Uno","year":"2014","journal-title":"Cloning & Transgenesis"},{"key":"10.1016\/j.yexcr.2020.111882_bib148","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/321977","article-title":"Functional complementation of a genetic deficiency with human artificial chromosomes","volume":"69","author":"Mejia","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2020.111882_bib149","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1365-2443.2002.00580.x","article-title":"Generation of human artificial chromosomes expressing naturally controlled guanosine triphosphate cyclohydrolase I gene","volume":"7","author":"Ikeno","year":"2002","journal-title":"Gene Cell."},{"key":"10.1016\/j.yexcr.2020.111882_bib150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0888-7543(03)00112-5","article-title":"Controlled transgene dosage and PAC-mediated transgenesis in mice using a chromosomal vector","volume":"82","author":"Voet","year":"2003","journal-title":"Genomics"},{"key":"10.1016\/j.yexcr.2020.111882_bib151","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.transproceed.2008.10.023","article-title":"Treatment of nonalbumin rats by transplantation of immortalized hepatocytes using artificial human chromosome","volume":"41","author":"Ito","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.yexcr.2020.111882_bib152","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3727\/000000008783906883","article-title":"Immortalized hepatocytes using human artificial chromosome","volume":"17","author":"Ito","year":"2008","journal-title":"Cell Transplant."},{"key":"10.1016\/j.yexcr.2020.111882_bib153","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/sj.gt.3302576","article-title":"Bacterial transfer of large functional genomic DNA into human cells","volume":"12","author":"Laner","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib154","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1089\/hum.2009.225","article-title":"Escherichia coli-cloned CFTR loci relevant for human artificial chromosome therapy","volume":"21","author":"Rocchi","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.mt.6300361","article-title":"Input DNA ratio determines copy number of the 33 kb Factor IX gene on de novo human artificial chromosomes","volume":"16","author":"Breman","year":"2008","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.yexcr.2020.111882_bib156","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00412-014-0488-3","article-title":"Generating a transgenic mouse line stably expressing human MHC surface antigen from a HAC carrying multiple genomic BACs","volume":"124","author":"Hasegawa","year":"2015","journal-title":"Chromosoma"},{"key":"10.1016\/j.yexcr.2020.111882_bib157","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jb\/mvq030","article-title":"Development of evaluation system for bioactive substances using human artificial chromosome-mediated osteocalcin gene expression","volume":"148","author":"Takahashi","year":"2010","journal-title":"J. Biochem."},{"key":"10.1016\/j.yexcr.2020.111882_bib158","series-title":"Murine Tissue Replacement Gene Therapeutic Model: Development of Mutant Induced Pluripotent Cells and the Recombinant Artificial Chromosome Vectors, Cell Technologies at the Edge: Research & Practice (CTERP)","first-page":"44","author":"Ponomartsev","year":"2016"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720300811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720300811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:28:02Z","timestamp":1757996882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482720300811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0014482720300811"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.111882","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human artificial chromosomes for pluripotent stem cell-based tissue replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.111882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111882"}}